Evidence map›Paper›PMID 31942456›Full record

ArticleCommunications chemistry2019

Auxiliary-assisted chemical ubiquitylation of NEMO and linear extension by HOIP.

Fabienne Burlina, Abu-Baker M Abdel-Aal, Richard Raz, Irene Pinzuti, George Papageorgiou, Jiejin Li, Robin Antrobus, Stephen R Martin, Simone Kunzelmann, Benjamin Stieglitz and 1 more

Abstract read
In one paragraph

Article in Communications chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Covalent chemical probes.Communications chemistry · 2025
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fabienne BurlinaSorbonne Université, École normale supérieure, PSL University, CNRS, Laboratoire des biomolécules, LBM, 75005 Paris, France.
Abu-Baker M Abdel-AalThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Richard RazThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Irene PinzutiDepartment of Biochemistry, School of Biological and Chemical Sciences, Queen Mary University of London, Mile End Road, London E1 4NS, UK.
George PapageorgiouThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Jiejin LiThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Robin AntrobusCambridge Institute for Medical Research, Cambridge Biomedical Campus, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 OXY, UK.
Stephen R MartinThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Simone KunzelmannThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Benjamin StieglitzDepartment of Biochemistry, School of Biological and Chemical Sciences, Queen Mary University of London, Mile End Road, London E1 4NS, UK.
John OfferThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Funding

Medical Research Council FC001999Wellcome Trust FC001999
6 · The paper itself

Abstract

The ubiquitylation of NF-κB essential modulator (NEMO) is part of the intracellular immune signalling pathway. Monoubiquitylated NEMO is required for exploring the mechanism of NEMO linear ubiquitylation by LUBAC (linear ubiquitin chain assembly complex), but is not accessible by biological techniques. Here we perform the chemical ubiquitylation of NEMO using a ligation auxiliary, which only requires a two-step synthesis, and is easily installed onto the lysine side-chain. Chemical ligation occurs directly on the lysine ε amine and remains efficient below pH 7. We show that ubiquitylated NEMO has similar affinity to linear diubiquitin chains as unmodified NEMO. The proximal ubiquitin of chemically synthesised NEMO

Identifiers

PMID31942456
PMCPMC6962051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.